BIO(Bio-Rad Laboratories, Inc.) · 财务报表

BIO(Bio-Rad Laboratories, Inc.) 的财务报表:医疗保健,医疗器械。数据来自 SEC 公开申报与市场行情,不构成投资建议。

近年年度财务(SEC XBRL)
科目FY 截至 2021-12-31FY 截至 2022-12-31FY 截至 2023-12-31FY 截至 2024-12-31FY 截至 2025-12-31
营业收入$2.92B$2.80B$2.67B$2.57B$2.58B
毛利润$1.64B$1.57B$1.43B$1.38B$1.34B
营业利润$500.34M$482.60M$337.80M$269.00M$47.20M
净利润$4.25B−$3.63B−$637.30M−$1.84B$759.90M
经营现金流$669.46M$194.40M$374.90M$455.20M$532.20M
自由现金流$535.72M$81.60M$218.20M$289.60M$374.60M
摊薄每股收益$140.83$-121.79$-21.82$-65.36$27.85

Bio-Rad Laboratories, Inc. BIO